BioZyme®, Inc. is proud to launch its newest brand, AO-Biotics®.
AO-Biotics is a line of fermentation products derived from BioZyme’s innovative fermentation of Aspergillus oryzae (AO) that promote resilience. As global experts in AO fermentation, BioZyme is excited to bring to market AO fermentation products that are “anything but ordinary.”
The first product addition to the AO-Biotics is Amaferm®. For the last 50-plus years, Amaferm has been the hallmark ingredient in BioZyme’s premier line of animal nutritional supplements and health products. It is a prebiotic research-proven to enhance digestibility.
While research continues to expand on Amaferm, BioZyme is also on track to develop new products under the AO-Biotics brand. These will include both prebiotics and postbiotics.
“We are very passionate about utilizing our expertise in AO fermentation to develop new products that address common challenges in animal agriculture globally,” said Lisa Norton, President and CEO.
BioZyme, a member of the International Science Association for Probiotics and Prebiotics (ISAPP), has long manufactured and marketed prebiotics. However, inaugural sales of postbiotics are scheduled for the first quarter of 2023. Postbiotics are defined by ISAPP as “a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host.” These may include inactivated microbial cells, cell components or metabolites. AO’s capacity to produce unique cell components and metabolites makes it ideal for generating innovative postbiotics.
“We are using AO as a bio-factory to create biotics that promote an animal’s resilience to overcome specific challenges, whatever those may be,” shared Lynsey Whitacre, Ph.D., Senior Manager of New Product Development. “It’s an innovative approach that we have proven works, but we are only beginning to scratch the surface of what is possible.”
To learn more about AO-Biotics, visit aobiotics.com.